CE Holdings Co., Ltd. (JP:4320)
:4320
Top Page
CE Holdings Co., Ltd.
(4320)
Select Model
Select Model
Rating:74Outperform
Price Target:
¥1,342.00
▲(28.05% Upside)
Action:ReiteratedDate:03/24/26
The score is driven primarily by solid financial fundamentals (improved profitability, low leverage, and stronger free cash flow), supported by attractive valuation (low P/E and high dividend yield). The main restraint is mixed technicals with muted near-term momentum and some weakness versus the 20-day average.
Positive Factors
Improved profitability & FCF
Free cash flow rose sharply in 2025 and has run close to net income over the last two years, supporting earnings quality. Improved profitability and stronger FCF enhance the firm's ability to fund operations, dividends, and strategic investments over the next several quarters.
Negative Factors
Recent sharp revenue decline
A pronounced revenue drop in the latest year reduces predictability of sales and weakens near‑term growth visibility. If cyclical or structural pressures persist, management may face tougher revenue recovery and margin stabilization challenges over the next several quarters.
Read all positive and negative factors
Positive Factors
Negative Factors
Improved profitability & FCF
Free cash flow rose sharply in 2025 and has run close to net income over the last two years, supporting earnings quality. Improved profitability and stronger FCF enhance the firm's ability to fund operations, dividends, and strategic investments over the next several quarters.
Read all positive factors
CE Holdings Co., Ltd. (4320) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥21.13B
Dividend Yield4.99%
Average Volume (3M)84.19K
Price to Earnings (P/E)11.6
Beta (1Y)0.85
Revenue Growth8.77%
EPS Growth1078.88%
CountryJP
Employees606
SectorHealthcare
Sector Strength45
IndustryMedical - Healthcare Information Services
Share Statistics
EPS (TTM)22.60
Shares Outstanding17,039,400
10 Day Avg. Volume92,620
30 Day Avg. Volume84,186
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)1.46
Price to Sales (P/S)0.76
P/FCF Ratio13.31
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
CE Holdings Co., Ltd. Business Overview & Revenue Model
Company Description
CE Holdings Co., Ltd., through its subsidiaries, develops and sells electronic medical record systems and medical information systems in Japan. The company provides MI RA Is (Miraize), an electronic medical record system for medical institutions. ...
CE Holdings Co., Ltd. Financial Statement Overview
Summary
Income Statement
72
Positive
Balance Sheet
78
Positive
Cash Flow
74
Positive
| Breakdown | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 15.83B | 14.55B | 13.63B | 13.70B | 12.28B |
| Gross Profit | 3.54B | 3.28B | 3.60B | 3.09B | 2.59B |
| EBITDA | 1.99B | 1.66B | 1.69B | 1.40B | 1.23B |
| Net Income | 1.56B | 123.42M | 687.53M | 588.00M | 632.93M |
Balance Sheet | |||||
| Total Assets | 12.78B | 11.27B | 11.26B | 10.92B | 9.48B |
| Cash, Cash Equivalents and Short-Term Investments | 5.03B | 3.83B | 3.14B | 3.96B | 2.87B |
| Total Debt | 1.47B | 2.27B | 1.42B | 1.89B | 1.37B |
| Total Liabilities | 3.94B | 4.67B | 4.67B | 4.83B | 4.00B |
| Stockholders Equity | 8.30B | 6.10B | 6.08B | 5.63B | 5.07B |
Cash Flow | |||||
| Free Cash Flow | 908.29M | 676.53M | 521.69M | 415.65M | 881.91M |
| Operating Cash Flow | 998.32M | 752.39M | 797.69M | 1.56B | 1.05B |
| Investing Cash Flow | 381.37M | -630.51M | -863.59M | -772.95M | -158.53M |
| Financing Cash Flow | -146.62M | 566.46M | -754.51M | 306.64M | -838.45M |
CE Holdings Co., Ltd. Technical Analysis
Positive
1048.00
Price Trends
1214.94
Positive
1124.74
Positive
931.89
Positive
Market Momentum
8.76
Negative
53.26
Neutral
66.16
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4320, the sentiment is Positive. The current price of 1048 is below the 20-day moving average (MA) of 1225.25, below the 50-day MA of 1214.94, and above the 200-day MA of 931.89, indicating a bullish trend. The MACD of 8.76 indicates Negative momentum. The RSI at 53.26 is Neutral, neither overbought nor oversold. The STOCH value of 66.16 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4320.
CE Holdings Co., Ltd. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥21.13B | 11.59 | ― | 4.99% | 8.77% | 1078.88% | |
70 Outperform | ¥1.14T | 18.91 | 12.15% | 1.01% | 33.50% | 17.26% | |
63 Neutral | ¥65.67B | 228.03 | ― | 0.39% | 6.17% | -8918.66% | |
63 Neutral | ¥241.79B | 26.76 | ― | 0.43% | 20.55% | 48.62% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
51 Neutral | ¥68.74B | 77.03 | 5.76% | ― | 31.95% | -40.95% |
* Healthcare Sector Average
JP:4320
CE Holdings Co., Ltd.
1,256.00
705.96
128.35%
JP:2413
M3
1,680.50
149.05
9.73%
JP:4480
Medley
2,100.00
-817.00
-28.01%
JP:3902
Medical Data Vision Co.Ltd.
1,684.00
1,327.00
371.71%
JP:4483
JMDC Inc.
3,695.00
1,044.89
39.43%
JP:366A
Wellness Communications Corporation
1,030.00
-733.59
-41.60%
CE Holdings Co., Ltd. Corporate Events
CE Holdings posts sharp Q1 profit jump but guides for lower full-year earnings and dividends
Feb 10, 2026
CE Holdings Co., Ltd. reported strong results for the three months ended December 31, 2025, with net sales up 33.2% year on year to ¥5.06 billion and operating profit jumping 68.0% to ¥655 million. Ordinary profit climbed 68.4% to ¥...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.